TipRanks
Go Ultimate55% OFF

Michael Severino Insider Profile

11 Followers

Michael Severino, Chief Executive Officer, Director at Sarepta Therapeutics, holds 756.10K shares in Sarepta Therapeutics (Ticker: SRPT), holds 85.82K shares in Avantor (Ticker: AVTR), holds 26.03K shares in Viatris (Ticker: VTRS).

Michael Severino's Trading History

SRPT
Sarepta Therapeutics
Jul 29, 2026Chief Executive Officer, DirectorUninformative Buy―$14.08M
AVTR
Avantor
May 11, 2026DirectorUninformative Buy―$1.38M
VTRS
Viatris
Mar 10, 2026DirectorUninformative Buy368.60K$495.50K
ABBV
AbbVie
May 25, 2022Vice ChairmanUninformative Buy8.70M$44.85M

You May Also Like

Michael Severino insider profile FAQ

What is the percentage of profitable transactions made by Michael Severino?
The percentage of profitable transactions made by Michael Severino is 67%.
What is the average return per transaction made by Michael Severino?
The average return per transaction made by Michael Severino is 2.40%.
What stocks does Michael Severino hold?
Michael Severino holds: SRPT, VTRS, ABBV, AVTR stocks.
What was Michael Severino's most profitable transaction?
Michael Severino’s most profitable transaction was an Informative Sell of ABBV stock on May 25, 2022. The return on the trade was 5.20%.
What is Michael Severino's role in Sarepta Therapeutics?
Michael Severino's role in Sarepta Therapeutics is Chief Executive Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.